The Effect of COVID-19 on Rib Fracture Patients in Michigan.
Allie EickholtzJeremy MormolJesse K KelleyMadi MangioneSteffen J PoundersRyan GrosecloseMatthew LypkaCharles GibsonAlistair ChapmanCathryn ChadwickLaura KrechPublished in: The American surgeon (2024)
This study aims to compare outcomes of rib fracture patients with and without COVID-19 in Michigan. Data from the Michigan Trauma Quality Improvement Program (MTQIP) identified adults hospitalized from January 1, 2020, to October 31, 2022, with at least one rib fracture and a completed COVID-19 test on admission. Patients were propensity score matched 1:1 using 20 variables. The primary outcome was hospital length of stay (LOS). Secondary outcomes were mortality, ventilator days, intensive care unit (ICU) LOS, pneumonia, and ventilator-assisted pneumonia (VAP). 13,305 total patients were identified. 232 patients matched into both the COVID+ and COVID- groups. COVID was associated with increased LOS (7 days vs. 5 days, P < 0.001). There were no significant differences between the two groups when evaluating secondary outcomes. Our study indicates that although COVID-19 infection is associated with increased LOS, COVID may not contribute to additional morbidity or mortality in traumatic rib fracture patients.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- intensive care unit
- newly diagnosed
- chronic kidney disease
- quality improvement
- prognostic factors
- healthcare
- type diabetes
- emergency department
- cardiovascular disease
- metabolic syndrome
- skeletal muscle
- spinal cord injury
- respiratory syndrome coronavirus
- patient safety
- patient reported
- data analysis
- hip fracture
- respiratory failure